Rosa Market Modeling is focused on quantifying the potential demand for pipeline products in the pharmaceutical and medical diagnostics industries.
We accomplish this by conducting online surveys with relevant physicians to identify what product attributes will drive prescriber preference for a new treatment and how your product’s potential range of performance on these attributes will compare to its competitors at launch and to anticipated new competitors in the future.
Our clients use the results from Rosa Market Modeling studies to inform internal discussions about the commercialization of the treatment based on estimated demand given various scenarios and product design decisions.
Areas of expertise:
|Company Headquarters||:||774 Stone Lane, Palo Alto, CA, 94303, United States|
|Executive Leadership||:||Ron Beaver, CEO|
Matt Marano, CCO
Rob Singer, Principal, Rosa Market Modeling
|Parent Company||:||Rosa & Co.|
|New Business Contact||:||Rob Singer|